Alvotech is a biotechnology company focused on the development and commercialization of high-quality biosimilar medicines

The company aims to provide affordable alternatives to branded biologic drugs, addressing the growing demand for cost-effective therapeutic options in various therapeutic areas. Alvotech leverages its proprietary technology platform to produce biosimilars that can offer similar safety and efficacy profiles to their reference products. Through strategic partnerships and a commitment to innovation, Alvotech strives to enhance patient access to vital medications on a global scale.